TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive NCAB Member David Koch Gives $100 Million To MIT For New Cancer Research Institute. October 12, 2007
TCL Archive Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial November 10, 1989
